The Scientist

» ALS

Most Recent

image: ALS Drug Access Debated

ALS Drug Access Debated

By | April 7, 2015

Biotech company Genervon has requested accelerated approval for its experimental ALS drug after a small but promising Phase 2 trial. Patients advocate for its acceptance, while researchers urge caution.

2 Comments

image: Beneficial Stats

Beneficial Stats

By | March 1, 2015

Statisticians who normally crunch numbers to forecast trends in the food-service industry turn their attention to bettering treatment of ALS.

0 Comments

The ALS Association has raised more than $100 million in donations through a charity campaign that went viral. How should that money be spent?

1 Comment

image: Ice Bucket Challenge Irony

Ice Bucket Challenge Irony

By | August 25, 2014

Several US legislators who voted in favor of a bill that cut federal funding for ALS research have taken the chilly plunge for charity.

4 Comments

image: Non-coding Repeats Cause Peptide Clumps

Non-coding Repeats Cause Peptide Clumps

By | February 7, 2013

Protein aggregates in the brains of some people with dementia or motor neuron disease have a surprising origin.

0 Comments

image: Medical Mavericks

Medical Mavericks

By | July 1, 2012

ALS patients take their fate into their own hands, self-administering an unapproved chemical and collating their results online.

11 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Biology Research
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Eppendorf
Eppendorf